Spazo2 (Sogug): Comparative Effectiveness Of Pazopanib In Metastatic Renal Carcinoma (Mrc): Ineligible (I) Vs Eligible (E) Patients For Clinical Trials

ANNALS OF ONCOLOGY(2017)

引用 2|浏览19
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要